J3299 HCPCS code: Injection, triamcinolone acetonide (xipere), 1 mg
J3299 is the HCPCS Level II code for injection, triamcinolone acetonide (xipere), 1 mg. In 2024 Medicare paid an average of $37.68 per service for J3299 across 67,528 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 72 per day on outpatient hospital claims. Medicare volume rose 730% from 2022 to 2024 (8,138 to 67,528 services). In 2024, about 343 clinicians billed Medicare for J3299 for 1,305 beneficiaries; Texas, Pennsylvania, Arizona accounted for 42% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-07-01 |
| Last action effective | 2022-07-01 |
Who bills J3299 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 343 |
| Medicare beneficiaries | 1,305 |
| States with claims | 27 |
| Share of services in top 3 states (Texas, Pennsylvania, Arizona) | 42% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3299, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 8,138 | 270 | $51.91 | $41.36 |
| 2023 | 40,182 | 847 | $46.89 | $37.33 |
| 2024 | 67,528 | 1,305 | $47.39 | $37.68 |
States with the most J3299 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 13,593 | $37.90 |
| Pennsylvania | 7,893 | $38.02 |
| California | 5,625 | $37.94 |
| Arizona | 5,625 | $37.97 |
| Florida | 4,870 | $37.64 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 72 | Anatomic Consideration |
| practitioner claims | 72 | Anatomic Consideration |
What changed for J3299
- 2022-07-01: J3299 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3299?
J3299 is the HCPCS Level II code for injection, triamcinolone acetonide (xipere), 1 mg. Short descriptor: "Inj xipere 1 mg".
How much does Medicare pay for J3299?
In 2024, the average Medicare payment was $37.68 per service (average allowed $47.39).
Does Medicare cover J3299?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3299 can be billed per day?
72 on outpatient hospital claims; 72 on practitioner claims (NCCI medically unlikely edits).
Related J32 codes
- J3230 — Injection, chlorpromazine hcl, up to 50 mg
- J3240 — Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3241 — Injection, teprotumumab-trbw, 10 mg
- J3243 — Injection, tigecycline, 1 mg
- J3244 — Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245 — Injection, tildrakizumab, 1 mg
- J3246 — Injection, tirofiban hcl, 0.25 mg
- J3247 — Injection, secukinumab, intravenous, 1 mg
- J3250 — Injection, trimethobenzamide hcl, up to 200 mg
- J3260 — Injection, tobramycin sulfate, up to 80 mg
- J3262 — Injection, tocilizumab, 1 mg
- J3263 — Injection, toripalimab-tpzi, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3299
- Watch J3299 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3299
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.